Florida’s Alzheimer’s Research Consortium Awarded $15 Million Grant to Focus on Diverse Populations

The 1Florida Alzheimer’s Disease Research Center, or 1Florida ADRC, a University of Florida-organized consortium of leading research institutions aimed at making Alzheimer’s and related dementias treatable, preventable and one day curable, has received a five-year, $15 million grant from the National Institutes of Health’s National Institute on Aging. The award will enable the consortium to continue and expand its work, with a heightened focus on further understanding dementias in diverse populations.

In the first funding cycle from 2015 to 2020, about 60 percent of the 1Florida ADRC’s research participants were Hispanic, a factor that distinguishes the 1Florida ADRC from the more than 30 other such centers in the country, said Todd Golde, M.D., Ph.D., principal investigator of the 1Florida ADRC and director of UF’s Evelyn F. and William L. McKnight Brain Institute. The vast majority of published data on Alzheimer’s disease has studied white people of European ancestry, a factor that could inaccurately skew conclusions about incidence, progression and risk factors, he said.

Learn more about Florida’s Alzheimer’s Research Consortium Awarded $15 Million Grant to Focus on Diverse Populations.